Health

ROMA (ITALPRESS) – “The National Health Fund exclusively finances the standard requirements for essential levels of assistance: the health expenses of the programmatic document also includes other extra Lea entities. In 2022 the Fund was 125 billion, in 2026 it […]

ROMA (ITALPRESS) – The presentation of the Rare Disease Document took place in Rome: towards early and equitable diagnosis, in the presence of institutions, scientific communities and patient associations, which proposes a unitary reading of the main clinical and organizational

ROMA (ITALPRESS) – Ensuring early diagnosis, structured grip and homogeneous access to innovative therapies for patients with transtiretin heart amyloidosis (ATTR): this is the objective of the press conference “Amiloidosi Cardiaca: towards a national model of early diagnosis, welfare continuity

ROMA (ITALPRESS) – An infection on six today no longer responds to antibiotics. It is the photograph that emerges from the most recent report of the World Health Organization: between 2018 and 2023, antimicrobial resistance has increased by more than

ROMA (ITALPRESS) – “I believe that with a changing world and a growing population, citizens ask us more and more health. That is why we have to focus a lot, and we are doing it, on prevention.” The Minister of

ROMA (ITALPRESS) – In Italy, in 2024 the resistance percentages to the main classes of antibiotics for the eight pathogens under surveillance continue to remain high, however for some pathogen/antibiotic combinations we continue to observe a decrease or substantially stable

PALERMO (ITALPRESS) – “An extraordinary turning point of political character. The new general directors will not be chosen only by the Junta, but first selected by a high commission, consisting of 3 subjects, one appointed by the President of the

FIRENZE (ITALPRESS) – More than 6 years after the arrival in Italy of the first anti-cancer gene therapy, CAR-T (acronym of Chimeric Antigens Receptor T-Cells), advanced therapies based on the modification and strengthening of T lymphocytes, which in this way

MILANO (ITALPRESS) – Daiichi Sankyo Italy has announced the availability in Italy of quizartinib for the treatment of adult patients with acute myeloid leukemia (LMA) FLT3-ITD positive (mutation of the FLT3 gene with internal tandem duplication) of new diagnosis, in

VERONA (ITALPRESS) – Not a simple information document, but a work tool for those who choose to contribute to change. The White Paper “History of Life with EGPA” is an opportunity for patients to give voice to their own lives